Enhancing Human Milk Production With Domperidone in Mothers of Preterm Infants

@article{Asztalos2017EnhancingHM,
  title={Enhancing Human Milk Production With Domperidone in Mothers of Preterm Infants},
  author={Elizabeth V. Asztalos and Marsha L. Campbell-Yeo and Orlando da Silva and Shinya Ito and Alex Kiss and David C. Knoppert},
  journal={Journal of Human Lactation},
  year={2017},
  volume={33},
  pages={181 - 187}
}
Background: Mothers of preterm infants often are at risk of expressing an inadequate amount of milk for their infants and the use of galactogogues is often considered. Domperidone is a widely used galactogogue with little information available to guide clinicians regarding initiation, timing, and duration of treatment. Research aim: The primary objective of this study was to determine whether administration of domperidone within the first 21 days after delivery would lead to a higher proportion… Expand
Evaluating the Effect of a 14-Day Course of Domperidone on Breast Milk Production: A Per-Protocol Analysis from the EMPOWER Trial.
TLDR
Taking into consideration potential limitations in power, this secondary analysis was able to show that the mothers in the EMPOWER study who were identified as actually completing a 14-day treatment course responded irrespective of the timing of their initiation of domperidone and demonstrated a modest increase in breast milk volume. Expand
Role of days postdelivery on breast milk production: a secondary analysis from the EMPOWER trial
TLDR
This secondary analysis was able to demonstrate that mothers of very preterm infants, < 30 weeks gestation at birth, were able to respond to the study treatment in a similar fashion regardless of timing of entry and exposure to domperidone. Expand
Human Milk Expression After Domperidone Treatment in Postpartum Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
TLDR
This meta-analysis reports a significant improvement in expressed human milk volume per day with the use of domperidone in mothers experiencing insufficient human milk production. Expand
Longer-term breastfeeding outcomes associated with domperidone use for lactation differs according to maternal weight
TLDR
Differences in domperidone effectiveness according to maternal weight have important implications for clinical practice given the increasing prevalence of overweight/obesity in reproductive-age women and their higher risk of low milk supply, highlighting the importance of further research in this area. Expand
Pregnancy gestation at delivery and breast milk production: a secondary analysis from the EMPOWER trial
TLDR
This secondary analysis was able to demonstrate that mothers of very preterm infants, < 30 weeks gestation at birth, were able to respond to the study treatment in a similar fashion regardless of gestation at Birth, and a 14–day treatment of domperidone may be considered to enhance breast milk production, even in the lowest gestational ages at delivery. Expand
Characterisation of sucking dynamics of breastfeeding preterm infants: a cross sectional study
TLDR
Synchronised ultrasound and intra-oral vacuum measurements show that the preterm infant generates vacuum by lowering their tongue in a parallel fashion, without distortion of the nipple/nipple shield. Expand
Supporting Mothers of Very Preterm Infants and Breast Milk Production: A Review of the Role of Galactogogues
TLDR
This review will focus on the pharmacologic galactogogues currently available and the literature related to their use in mothers of very preterm infants. Expand
Feasibility and Acceptability of Metformin to Augment Low Milk Supply: A Pilot Randomized Controlled Trial
TLDR
Although results trend toward hypothesized direction, trial feasibility concerns include late enrollment and only 20% of metformin-assigned participants sustaining improved milk output to Day 28, with none perceiving met formin worthwhile. Expand
RETRACTED: Galactogogues use Among Mothers With Preterm Births: A Systematic Review and Meta-Analysis
TLDR
Herbal galactogogues may be more effective for longer term use, although there is still limited evidence to support its prescription to preterm mothers. Expand
Domperidone Versus Metoclopramide: Self-Reported Side Effects in a Large Sample of Breastfeeding Mothers Who Used These Medications to Increase Milk Production
TLDR
The results of the present study suggest that cardiac arrhythmias are a rare side effect with both medications, and recommendations regarding the relative safety of these medications will be re-examined in light of these findings. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 18 REFERENCES
The Effect of Two Different Domperidone Doses on Maternal Milk Production
TLDR
A dose of domperidone of 20 mg, 3 times daily instead of 10 mg,3 times daily was associated with a clinical, but not statistically significant, increase in milk production, which was not significant within- or between-group difference. Expand
Enhancing breast milk production with Domperidone in mothers of preterm neonates (EMPOWER trial)
TLDR
EMPOWER was designed to determine the safety and efficacy of domperidone in mothers experiencing an inadequate milk supply and provide valuable information in guiding the practices for this high-risk group of infants and mothers. Expand
Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial.
TLDR
In the short term domperidone increases milk production in women with low milk supply and is detected at low levels in breast milk. Expand
Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial
TLDR
Oral domperidone and metoclopramide increased the volume of milk produced by mothers who are expressing to feed their babies in NICU, and there were small differences in milk output between the two medications. Expand
Effect of Domperidone on the Composition of Preterm Human Breast Milk
TLDR
Domperidone increases the volume of breast milk of preterm mothers experiencing lactation failure, without substantially altering the nutrient composition. Expand
Use of Domperidone as a Galactagogue Drug
  • C. Paul, M. Zénut, +4 authors D. Balayssac
  • Medicine
  • Journal of human lactation : official journal of International Lactation Consultant Association
  • 2015
TLDR
The benefit-risk ratio of domperidone as a galactagogue was assessed following a literature search of the PubMed database up to July 2013 and an improvement of breastfeeding practices seems to be more effective and safer than the use of an off-label domperidine treatment. Expand
Effect of Preterm Birth and Antenatal Corticosteroid Treatment on Lactogenesis II in Women
TLDR
Delivery at extremely preterm gestational ages caused a significant delay in the onset of lactogenesis II, and the volume of milk was reduced when antenatal corticosteroids were administered between 28 and 34 weeks' gestation and delivery occurred 3 to 9 days later. Expand
Postpartum domperidone use in British Columbia: a retrospective cohort study.
TLDR
An increase in postpartum domperidone use over a 10-year period is found, and women who were older, had a higher body mass index,Had a chronic disease, were first-time mothers, delivered more than 1 baby, had an preterm birth or had a cesarian delivery were more likely to fill a postpartums domperodone prescription. Expand
Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial
TLDR
Low-dose dexamethasone treatment after the first 1 week of life clearly facilitates extubation and shortens the duration of intubation among ventilator-dependent, very preterm/extremely low birth weight infants, without any obvious short-term complications. Expand
Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products.
TLDR
An exclusive human milk diet, devoid of CM-containing products, was associated with lower mortality and morbidity in EP infants without compromising growth and should be considered as an approach to nutritional care of these infants. Expand
...
1
2
...